Volunteering

Volunteering

The role of study volunteers in clinical research is crucial in the advancement of medicine. Without volunteer participation, new ways to prevent, diagnose, and treat diseases cannot be achieved.

We're Here to Answer Your Questions

Our recruitment staff is available Monday through Friday to answer your questions. If you call outside these hours, leave a message, and your call will be returned. If you are interested in a study for healthy volunteers, please call 919-613-6244. If you are interested in a study for a specific medical condition, please call 919-613-6246.

contextual photo

Volunteer Registry

If you are interested in being contacted for future research studies when it appears that you may be eligible based on the information you provide us, join our Research Volunteer Registry.


Additionally, you can view our other study opportunities below.

Asthma Patient Registry

The Duke Early Phase Clinical Research Unit is enrolling people with asthma into the American Lung Association's Asthma Clinical Research Center patient registry. If you have asthma and are interested in becoming involved in ALA-sponsored studies, you may participate in the registry regardless of your smoking status. Registry participants will play a role in furthering medical knowledge about the condition and be notified of any studies they might be qualified to participate in.

For more information

Please contact the Duke Early Phase Clinical Research Unit at 919-684-1554 or dcrurecruit@duke.edu.

Investigational Drug for Type 2 Diabetes

Men and women between the ages of 21 and 70 who have been diagnosed with type 2 diabetes are needed to participate in the study of an investigational drug. The drug is being developed as a potential treatment to possibly improve blood sugar and cholesterol levels.

Participants must be using metformin to treat diabetes. Participation will involve 10 visits to the Duke Early Phase Clinical Research Unit. Enrolled participants will receive financial compensation for their time.

For more information

Please contact the Duke Early Phase Clinical Research Unit at dcrurecruit@duke.edu.

Flu Vaccine Research Study

Men and women between the ages of 19 and 64 are needed to participate in a research study to determine the safety, tolerability, and activity of an investigational vaccine that is being developed as a potential treatment against a specific strain of the bird flu. Participation requires 12 outpatient visits over the course of approximately 13 months.

During the course of the study, participants will receive 2 doses of the study vaccine. Enrolled participants will receive financial compensation.

For more information

Please contact the Duke Early Phase Clinical Research Unit at 919-613-6244 or dcrurecruit@duke.edu.

Drug Study for Skin Disease

Volunteers with various types of skin disease are needed to participate in a research study to assess the safety, tolerability, and activity of an investigational drug that is being developed as a potential treatment for plaque psoriasis, palmoplantar pustulosis, or hidradenitis suppurativa. Eligible participants will be men and women who are at least 18 years old and are not currently using a biologic agent to treat their skin disease. Participation involves 15 outpatient visits to the Duke Early Phase Clinical Research Unit over the course of approximately 5 months.

Study volunteers might receive a placebo rather than the active study drug. Compensation is provided to enrolled participants.

For more information

Please contact the Duke Early Phase Clinical Research Unit at 919-613-6244 or dcrurecruit@duke.edu.